Pınar GÜRSOY
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Araştırma alanları: Sağlık Bilimleri, Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Cerrahi Tıp Bilimleri, Yaşam Bilimleri, Patoloji, Temel Bilimler, Temel Eczacılık Bilimleri
Yayınlar
- Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group (2026)
- The effect of immunonutritional support in patients undergoing surgery and adjuvant chemotherapy for lung cancer (2026)
- Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group (2025)
- Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach (2025)
- Efficacy and Safety of the Topotecan–Cyclophosphamide Regimen in Adult Metastatic Ewing Sarcoma: A Large, Multicenter, Real-World Study (2025)
- Palbosiklib–letrozol ve ribosiklib–letrozol kombinasyonlarının metastatik HR+ / HER2- meme kanserinde birinci basamak tedavide etkinlik ve güvenlilik açısından karşılaştırılması (2025)
- Metastatik pankreas kanserinde birinci basamak tedavi: FOLFIRINOX ile gemsitabin-sisplatin rejimlerinin etkinlik ve güvenlik açısından karşılaştırılması (2025)
- Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study (2025)
- Clinicopathologic Determinants of Lymph Node Count and Prognostic Significance of Metastatic Lymph Node Ratio in Colorectal Cancer (2025)
- Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study (2025)
- Importance of the ratio of surgical margin to nodule size in pulmonary metastasectomy for colorectal carcinoma (2025)
- Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group (2025)
- Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program (2025)
- Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first‐line therapy in advanced nonuterine leiomyosarcoma: A multicenter real‐world study (2025)
- Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases (2024)
- Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study (2024)
- A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy (2024)
- Response rates of pazopanib therapy in metastatic soft tissue sarcoma using real‑world data (2024)
- Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic LymphomakinasePositive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib (2023)
- Prognosis-related novel immunostaining pattern for programmed cell death ligand 1 and prognostic value of tumour-infiltrating lymphocytes in triple-negative breast cancer (2023)
- Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC? (2023)
- IMPORTANCE OF THE RATIO OF THE SURGICAL MARGIN TO NODULE SIZE IN PULMONARY METASTASECTOMY FOR COLORECTAL CARCINOMA (2023)
- Malnutrition as a Prognostic Factor in the Survival of Patients With Gastric Cancer (2023)
- Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience (2022)
- Avascular necrosis during alectinib treatment: Case report (2022)
- Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy (2022)
- Impact of systemic inflammatory markers in patients with ALK -positive non-small cell lung cancer treated with crizotinib (2022)
- Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study (2022)
- The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study (2022)
- Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group (2022)
- Ado-trastuzumab emtansine associated spider telangiectasia. (2022)
- PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment (2022)
- PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment (2021)
- Predictive role of neutropenia under crizotinib treatment in ALK-rearranged nonsmall cell lung cancer patients (2021)
- Evaluation of treatment efficacy of tyrosine kinase inhibitors in rare single EGFR Exon 21 L861Q mutation; single center experience. (2021)
- Real Life Comparison of Afatinib and Erlotinib in Non-small Cell Lung Cancer With Rare EGFR Exon 18 and Exon 20 Mutations: a Turkish Oncology Group (TOG) Study. (2021)
- Neoadjuvan tedavide Pertuzumab alan meme kanseri hastalarının genel özellikleri (2021)
- Denovo metastatik pankreas kanserinde FOLFİRİNOX tedavisi sırasında gelişen hipoalbumineminin sağkalım üzerine etkisinin değerlendirilmesi (2021)
- Re-use of erlotinib in a patient using osimertinib after erlotinib, case report (2021)
- nadir tümörler (2020)
- The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience (2020)
- Metastatik Akciğer Adenokanserli Olguda İlk Hat Tedavi Olarak Alektinib Deneyimi (2019)
- Ege Üniversitesi Hastanesinde testis kanserlerinin epidemiyolojisi ve genel sağ kalım özellikleri (2019)
- Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC? (2019)
- TANI ANINDA OVER KANSERİ VE REKTUM KANSERİ OLAN OLGUDA KEMOTERAPİ VE CERRAHİ SONRASI TAM YANIT (2019)
- Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer (2019)
- ileri yaşta braf mutant metastatik kolorektal kanserli bir olgu sunumu (2019)
- LOKAL BÖLGESEL NÜKS İLE SEYREDEN OLİGOMETASTATİK BİR LARİNKS KARSİNOMU OLGUSU (2019)
- Ege U¨niversitesi Hastanesinde renal kanser hastalarının epidemiyolojisi ve genel sagˆ kalım o¨zellikleri (2019)
- Ege U¨niversitesi Hastanesinde testis kanserlerinin epidemiyolojisi ve genel sagˆ kalım o¨zellikleri (2019)
- METASTATİK KOLOREKTAL KANSERDE MULTİHAT KEMOTERAPİ VE SİTOREDÜKTİF CERRAHİ-HIPEC İLE TAM YANIT ALINAN HASTA (2019)
- Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC? (2019)
- METASTATİK İNCE BAGIRSAK İYİ DİFERANSİYE NÖROENDOKRİN TÜMÖR TEDAVİSİ HASTALIK YÖNETİMİ OLGU SUNUMU (2019)
- EXON 19 delesyonu saptanan skuamöz hücreli akciğer karsinomunda afatinib tedavisi (2019)
- Long-Term Follow-Up of Patients with Male Breast Cancer, Single-Center Experience (2019)
- Ege Üniversitesi Hastanesinde testis kanserlerinin epidemiyolojisi ve genel sağ kalım özellikleri (2019)
- The Evaluation of Effificacy and Tolerability of Regorafenib Treatment in Metastatic Colorectal Cancer: Single Center Experience (2019)
- Ege Üniversitesi Hastanesinde renal kanser hastalarının epidemiyolojisi ve genel sağ kalım özellikleri (2019)
- Nadir görülen fakat agresif seyir gösteren endokrin tümör:dev adrenal kortikal karsinom vakası (2019)
- Nadir görülen bir vaka:kras exon 3 mutasyonu (2019)
- Metastatik Kolorektal Kanserde Regorafenib Kullanımının Etkinlik ve Yan Etki Açısından Değerlendirilmesi. (2019)
- Adrenokortikal karsinom: Tek merkez deneyimi (2019)
- P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey (2018)
- Liquid biopsy for EGFR mutations in non-small cell lung cancer cases by RT-PCR (2018)
- Liquid Biopsy in Lung Cancer: Tepecik Experience (2018)
- Akciğer Kanserinde Sıvı (Liquid) Biyopsi Tepecik Deneyimi (2018)
- dahili tıp bilimleri (2018)
- The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome (2018)
- Liquid Biopsy in Lung Cancer: Tepecik Experience (2018)
- Prognostic role of surrogate intrinsic subtypes in non-metastatic inflammatory breast cancer (2015)
- Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway (2015)
- Trastuzumab/At-101 Combination Induces Apoptosis and Shows Synergistic Cytotoxicity in Her2-Positive Breast Cancer Cells By Inhibition of Pi3K Signaling: a Novel Combination to Overcome Resistance to Anti-Her2 Therapy (2014)
- Trastuzumab HER2 Pozitif Meme Kanseri Hücrelerini Radyasyon Uygulamasına Karşı Sensitize Etmektedir (2014)
- Meme Kanseri Moleküler Genetik Alt Sınıflarının 35 ve 35 Yaş kadınlarda Karşılaştırılması (2014)
- THE EFFECTS OF RALOXIFENE ON OSTEOCALCIN, AS A BONE TURNOVER MARKER IN ORCHIECTOMIZED RATS (2014)
- Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer (2013)
- Paclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells. (2013)
- Interpreting Genomic Diversity for Breast Cancer: Molecular Subtypes of Breast Cancer in Very Young Women (≤35 Y) in Western Turkey (2013)
- Trabectedin in Meme Kanseri Hücre Kültürlerinde DNA Metiltransferaz ve Histon Deasetilaz Aktiviteleri Üzerindeki Etkileri (2013)
- AT 101 in HUVEC Hücre Kültürlerinde Hücre Göçüne Etkileri Bakımından Çeşitli Ajanlarla Karşılaştırılması (2013)
- Glioblastoma Multiforme Hücre Kültürlerinde U 87 MG Ve T98G Trabectedin Aracılı Sitotoksik Etkide DNA Tamir Mekanizmalarının Rolü (2013)
- Meme Kanseri Kök Hücre ve Heterojen Kültürlerde AT 101 ve Paklitaksel Kombinasyonu Aracılı Farklılaşan Sitotoksik Etki (2013)
- Comparison of a Novel Label Free and Real Time Cell Based System Xcelligence with a Conventional Viability Assay XTT to Determine The Anti Proliferative Effect of AT 101 in Human Breast Cancer Cells (2012)
- Metastatik Renal Hücre Karsinom Hastalarda Sunitinib Etkinlik ve Toksisitesinin Değerlendirilmesi. (2012)
- 99P Zoledronic Acid in Combination with Serine/Threonine Phosphatase Inhibitors Induces Cytotoxicity and Apoptosis in Human Breast Cancer Cells via Decreasing the Activities of Pp1 and Pp2A (2012)
- 94P Comparison of A Novel, Label-Free, and Real-Time cell Based System (Xcelligence) With a Conventional Viability Assay (Xtt) to Determine the Anti-Proliferative Effect of At-101 in Human Breast Cancer Cells (2012)
- ZOLEDRONIC ACID IN COMBINATION WITH SERINE/THREONINE PHOSPHATASE INHIBITORS INDUCES CYTOTOXICITY AND APOPTOSIS IN HUMAN BREAST CANCER CELLS VIA DECREASING THE ACTIVITIES OF PP1 AND PP2A (2012)
- Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency? (2009)
- Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer.
- Paclitaxel in combination with AT-101 induces apoptosis via supressing Bcl-2, bcl-XL, mcl-1 proteins in human breast cancer cells.